Edition:
United Kingdom

Cerus Corp (CERS.OQ)

CERS.OQ on NASDAQ Stock Exchange Global Market

3.64USD
8 Dec 2017
Change (% chg)

-- (--)
Prev Close
$3.64
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
172,578
52-wk High
$5.35
52-wk Low
$1.93

Select another date:

Tue, Nov 7 2017

BRIEF-Cerus receives IDE approval to initiate phase iii recepi study

* Cerus Corporation receives IDE approval to initiate phase iii recepi study Source text for Eikon: Further company coverage:

BRIEF-Cerus Corp reports Q3 loss per share $0.12

* Q3 earnings per share view $-0.15 -- Thomson Reuters I/B/E/S

BRIEF-Cerus and Kedrion Biopharma enter distribution agreement for full INTERCEPT blood system portfolio

* Cerus and Kedrion Biopharma enter distribution agreement for the full INTERCEPT blood system portfolio in Italy

BRIEF-Cerus announces agreement with transfusion Center of the Community of Madrid

* Cerus announces agreement with transfusion Center of the Community of Madrid

BRIEF-CERUS ANNOUNCES NATIONAL GERMAN REIMBURSEMENT FOR PATHOGEN INACTIVATED PLATELETS

* CERUS SAYS ‍INSTITUTE FOR HOSPITAL REMUNERATION SYSTEM IN GERMANY WILL INCLUDE PATHOGEN-INACTIVATED PLATELETS FOR NATIONAL REIMBURSEMENT STARTING JAN 1, 2018​ Source text for Eikon: Further company coverage:

BRIEF-Cerus Corp files for mixed shelf of up to $250 mln - SEC filing‍​

* Cerus Corp files for mixed shelf of up to $250 million - SEC filing‍​ Source text: (http://bit.ly/2wfbOni) Further company coverage:

BRIEF-Cerus Q2 loss per share $0.16

* Q2 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S

BRIEF-Cerus enters into $40 mln amended growth capital agreement

* Cerus enters into $40 million amended growth capital agreement

BRIEF-Cerus expands agreement with French National Blood Service

* Cerus announces expanded supply agreement with french national blood service

Select another date: